Science
Mechanism of Action
This ingredient primarily functions through its SH-Oligopeptide-1 component, which acts as an Epidermal Growth Factor (EGF). EGF precisely binds to epidermal growth factor receptors (EGFR) on skin cells, particularly keratinocytes. This binding initiates a cascade of intracellular signals that promote critical cellular activities, including increased cell division, growth, and differentiation. Furthermore, it enhances skin repair mechanisms by accelerating self-regeneration, stimulating the formation of new blood vessels, boosting endogenous rejuvenating growth factors, and reinforcing the skin's barrier function. It also contributes to minimizing inflammatory responses, reducing the appearance of cutaneous scars, providing long-term hydration, and increasing the production of vital extracellular matrix components like collagen, elastin, and hyaluronic acid.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
Information regarding 'dusting' or common misuse as a marketing ingredient without sufficient concentration is not available in the provided research data.
The Formula
Formulation
Stability
This ingredient, specifically its Oligopeptide-1 component, demonstrates significant pH sensitivity. Optimal stability is maintained within a pH range of 5 to 8. Formulations should have their pH adjusted within this range before the addition of the diluted EGF solution. Vigilant avoidance of microbial contamination during processing is crucial, as enzymatic degradation by microorganisms can compromise its stability and efficacy.
Safety
Safety Profile
Specific safety assessments from regulatory bodies such as CIR, SCCS, or FDA for R-(OLIGOPEPTIDE-133 SH-OLIGOPEPTIDE-1) are currently unavailable. While sh-Oligopeptide-1 (EGF) is authorized for general cosmetic use, its long-term risks are not fully understood. It is classified as mitogenic, meaning it stimulates cell proliferation, but it is not considered mutagenic. Due to its mitogenic nature, caution is advised for individuals with pre-existing skin cancer risk factors or psoriasis, as EGF could theoretically support the proliferation of existing cancerous cells. Reported side effects are generally minor, however, further comprehensive research specific to this complex peptide is required to establish its full safety profile.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While the SH-Oligopeptide-1 component (EGF) offers significant theoretical benefits for skin regeneration and repair, the lack of specific clinical studies and safety assessments for R-(OLIGOPEPTIDE-133 SH-OLIGOPEPTIDE-1) necessitates further research for a definitive Moumoujus endorsement.
Related
Similar Ingredients
Finding similar ingredients…